Named on one round in the feed.
Since 2022-07-20
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
BigHat Biosciences, Inc. A clinical-stage, AI-driven protein therapeutics platform company | Series B Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $75M | 2022-07-20 | [ LEAD ] |